Application YC di Relevium Medical

Summer 2022Active

Relevium Medical ha partecipato a Y Combinator nel batch Summer 2022 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2022
Settore: HealthcareTherapeutics
Dimensione team: 5
Stato: Active
Lanciata: 2022

Founder

Alison LiddyFounder

Cosa fa Relevium Medical

Relevium Medical is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease. Right now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease is progressive and only gets worse over time, many patients end up on highly addictive, high-dose opioids. To date, we have secured $3.7 million in non dilutive funding and completed preclinical testing. We demonstrated that our drug is safe, selectively blocks nerves that transmit pain, and provides pain relief that lasts four times as long. Insurance currently pays $770 per six-monthly treatment for knee osteoarthritis. With 5 million patients in the US, this represents a $7.7 Bn market opportunity. This platform biotherapeutic can also be used to treat other joints affects by osteoarthritis such as the hip and ankle, where the same problems exist in treatment care.

Application YC di Relevium Medical, ricostruita

Domanda per Y Combinator

Relevium Medical, batch Summer 2022. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Relevium Medical

Describe what your company does in 50 characters or less.

Injectable gel therapy for osteoarthritis

What is your company going to make? Please describe your product and what it does or will do.

We are developing a platform injectable gel designed to provide long-lasting pain relief for knee osteoarthritis patients. Our gel selectively blocks the pain-transmitting nerves and significantly extends the duration of relief compared to current treatments. It aims to reduce reliance on repeated injections and opioids.

Where do you live now, and where would the company be based after YC?

We live and work in Galway, County Galway, Ireland, and plan to keep the company based there after YC.

Explain your decision regarding location.

We are based in Galway where we have access to local talent and medical expertise relevant to our therapeutic development. Remaining here supports our preclinical testing and product development continuity.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Relevium Medical?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Relevium Medical (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Relevium Medical si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Relevium Medical?

Relevium Medical apparteneva al batch Summer 2022 di Y Combinator.

Chi ha fondato Relevium Medical?

Relevium Medical è stato fondato da Alison Liddy.

Cosa fa Relevium Medical?

Platform injectable gel based therapeutic for osteoarthritis

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Relevium Medical, e di ogni altro batch YC, è in YC Insights.